News | February 23, 2022
Agilent posts Q1 FY2022 revenue at US$ 1.67 billion
Revenue of $1.67 billion represents 8% reported growth; and up 9% on a core(basis.
Revenue of $1.67 billion represents 8% reported growth; and up 9% on a core(basis.
The company has reported total income of Rs.3031 crores during the calendar year ended December 31, 2021.
The sale is expected to close in the first quarter of 2022
He will be responsible for developing the company's pipeline of partnered and in-house discovery programs,
The COVID-19 pandemic has triggered the rapid growth of the biotherapeutics market
According to the state government, it will also provide support to special projects such as preclinical testing, genome sequencing in the private sector, private sector BSL-3 lab-vaccine development and manufacturing and testing and certification laboratories
The company registered consolidated total revenue of Rs 590.70 crore for Q3FY22.
ArisGlobal's industry-leading regulatory software chosen by top pharmaceutical company for IDMP preparation and global readiness
AptarGroup acquired Voluntis and 80% of Weihai Hengyu Medical Products in 2021.
The construction is scheduled to begin in the third quarter of the calendar year 2022, with expected completion in early 2024
Subscribe To Our Newsletter & Stay Updated
